TipRanks
Arbutus Biopharma Corporation (DE:I9DN)
FRANKFURT:I9DN
Germany Market
I9DN
Arbutus Biopharma
RESEARCH TOOLSreports

Arbutus Biopharma (I9DN) Income Statement

1 Followers

Arbutus Biopharma Income Statement

Last quarter (Q2 2026), Arbutus Biopharma's total revenue was $1.01M, a decrease of -90.56% from the same quarter last year. In Q2, Arbutus Biopharma's net income was $-5.14M. See Arbutus Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 14.08M$ 6.17M$ 18.14M$ 39.02M$ 10.99M
Gross Profit
$ 13.72M$ 6.17M$ 18.14M$ 39.02M$ 10.99M
Operating Expenses
$ 40.77M$ 82.49M$ 96.24M$ 104.47M$ 84.51M
Depreciation and Amortization
$ 363.00K$ 1.38M$ 1.40M$ 1.43M$ 1.75M
EBITDA
$ -33.04M$ -68.40M$ -70.99M$ -61.86M$ -71.64M
Operating Income
$ -27.05M$ -76.32M$ -78.10M$ -65.46M$ -73.52M
Other Income/Expenses
$ -6.45M$ 6.40M$ 5.25M$ 444.00K$ -2.73M
Pretax Income
$ -33.50M$ -69.92M$ -72.85M$ -65.01M$ -76.25M
Net Income
$ -33.50M$ -69.92M$ -72.85M$ -69.46M$ -76.25M
Per Share Metrics
Basic EPS
$ -0.17$ -0.38$ -0.44$ -0.46$ -0.73
Diluted EPS
$ -0.17$ -0.38$ -0.44$ -0.46$ -0.73
Weighted Average Shares Outstanding
 191.60M 185.61M 165.96M 150.94M 106.24M
Weighted Average Shares Outstanding (Diluted)
 191.60M 185.61M 165.96M 150.94M 106.24M
Currency in USD

Arbutus Biopharma Earnings and Revenue History